China
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
2022-03-17